Comments
Loading...
Nektar Therapeutics Insider Trading Activity | NASDAQ:NKTR | Benzinga
Track the latest Nektar Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Nektar Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Nektar Therapeutics Insiders Doing?
At Nektar Therapeutics, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 45.11K shares worth $45.57K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 21, 2025, Jonathan Zalevsky, the company's CHIEF R&D OFFICER sold 10.3K shares for $1.01 each.
- On February 21, 2025, Mark A. Wilson, the company's CHIEF LEGAL OFFICER sold 11.04K shares for $1.01 each.
- On February 21, 2025, HOWARD ROBIN, the company's PRESIDENT & CEO sold 23.77K shares for $1.01 each.
Ownership Statistics for Nektar Therapeutics
Shares Outstanding
184.458M
Insider Shares Owned
5.250M
Insider Percentage Owned
2.85%
Institutional Shares Held
57.447M
Institutional Percentage Held
31.1%
Data brought to you by Benzinga APIs
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.